| Original language | English |
|---|---|
| Pages (from-to) | 620-622 |
| Number of pages | 3 |
| Journal | Journal of the American College of Cardiology |
| Volume | 81 |
| Issue number | 6 |
| DOIs | |
| State | Published - Feb 14 2023 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American College of Cardiology, Vol. 81, No. 6, 14.02.2023, p. 620-622.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income Countries
AU - Global Health & Population Project on Access to Care for Cardiometabolic Disease (HPACC)
AU - Zhu, Jing Jing Z.
AU - Manne-Goehler, Jennifer
AU - Agarwal, Anubha
AU - Bahendeka, Silver K.
AU - Damasceno, Albertino
AU - Marcus, Maja E.
AU - Saeedi Moghaddam, Sahar
AU - Vollmer, Sebastian
AU - Huffman, Mark D.
AU - Flood, David
AU - Andall-Brereton, Glennis
AU - Aryal, Krishna
AU - Atun, Rifat
AU - Bicaba, Brice
AU - Davies, Justine
AU - Dorobantu, Maria
AU - Farzadfar, Farshad
AU - Geldsetzer, Pascal
AU - Gurung, Mongal
AU - Guwatudde, David
AU - Houehanou, Corine
AU - Hwalla, Nahla
AU - Joseph, Kibachio
AU - Karki, Khem
AU - Martins, Joao
AU - Norov, Bolormaa
AU - Quesnel-Crooks, Sarah
AU - Sibai, Abla
AU - Theilmann, Michaela
AU - Tsabedze, Lindiwe
N1 - Funding Information: Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number K23HL161271. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr Agarwal has pending patents for heart failure polypills. Dr Huffman has received travel support from the American Heart Association and World Heart Federation; has an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines; and has pending patents for heart failure polypills. Dr Flood has volunteer affiliations with the Guatemalan nongovernmental health organizations, Wuqu’ Kawoq and GlucoSalud, and occasionally seeks funding for cardiovascular care delivery. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Additional contributing collaborators from the Global Health & Population Project on Access to Care for Cardiometabolic Disease (HPACC): Glennis Andall-Brereton, Krishna Aryal, Rifat Atun, Brice Bicaba, Justine Davies, Maria Dorobantu, Farshad Farzadfar, Pascal Geldsetzer, Mongal Gurung, David Guwatudde, Corine Houehanou, Nahla Hwalla, Kibachio Joseph, Khem Karki, Joao Martins, Bolormaa Norov, Sarah Quesnel-Crooks, Abla Sibai, Michaela Theilmann, and Lindiwe Tsabedze. Data included in this study are publicly available for 37 of the 40 surveys. A complete list of web addresses and contacts regarding data access is presented in Marcus et al 2 (page 29 of the supplemental materials). Replication code is available at the Harvard Dataverse: https://doi.org/10.7910/DVN/PTWHHJ. Funding Information: Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number K23HL161271. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr Agarwal has pending patents for heart failure polypills. Dr Huffman has received travel support from the American Heart Association and World Heart Federation; has an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines; and has pending patents for heart failure polypills. Dr Flood has volunteer affiliations with the Guatemalan nongovernmental health organizations, Wuqu’ Kawoq and GlucoSalud, and occasionally seeks funding for cardiovascular care delivery. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Additional contributing collaborators from the Global Health & Population Project on Access to Care for Cardiometabolic Disease (HPACC): Glennis Andall-Brereton, Krishna Aryal, Rifat Atun, Brice Bicaba, Justine Davies, Maria Dorobantu, Farshad Farzadfar, Pascal Geldsetzer, Mongal Gurung, David Guwatudde, Corine Houehanou, Nahla Hwalla, Kibachio Joseph, Khem Karki, Joao Martins, Bolormaa Norov, Sarah Quesnel-Crooks, Abla Sibai, Michaela Theilmann, and Lindiwe Tsabedze. Data included in this study are publicly available for 37 of the 40 surveys. A complete list of web addresses and contacts regarding data access is presented in Marcus et al 2 (page 29 of the supplemental materials). Replication code is available at the Harvard Dataverse: https://doi.org/10.7910/DVN/PTWHHJ .
PY - 2023/2/14
Y1 - 2023/2/14
UR - http://www.scopus.com/inward/record.url?scp=85147295752&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2022.12.003
DO - 10.1016/j.jacc.2022.12.003
M3 - Letter
C2 - 36754520
AN - SCOPUS:85147295752
SN - 0735-1097
VL - 81
SP - 620
EP - 622
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 6
ER -